Literature DB >> 9704795

Effect of sexual intercourse on fetal fibronectin concentration in cervicovaginal secretions.

K Shimoya1, K Hashimoto, T Shimizu, F Saji, Y Murata.   

Abstract

An investigation was performed evaluating persistence of fetal fibronectin in cervicovaginal secretions after sexual intercourse. Fetal fibronectin samples were positive at 12 to 24 hours, 24 to 48 hours, and 48 to 72 hours after coitus in 22.2%, 11.8%, and 5.6% of samples, respectively. A history of vaginal intercourse should be obtained before sampling for fetal fibronectin to eliminate this potential source of false-positive fibronectin test.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704795     DOI: 10.1016/s0002-9378(98)70280-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review.

Authors:  Honest Honest; Lucas M Bachmann; Janesh K Gupta; Jos Kleijnen; Khalid S Khan
Journal:  BMJ       Date:  2002-08-10

Review 2.  Human cervicovaginal fluid biomarkers to predict term and preterm labor.

Authors:  Yujing J Heng; Stella Liong; Michael Permezel; Gregory E Rice; Megan K W Di Quinzio; Harry M Georgiou
Journal:  Front Physiol       Date:  2015-05-13       Impact factor: 4.566

3.  Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial).

Authors:  Jolande Y Vis; Femke F Wilms; Martijn A Oudijk; Martina M Porath; Hubertina C J Scheepers; Kitty W M Bloemenkamp; Annemiek C Bolte; Jérôme Cornette; Jan B Derks; Johannes J Duvekot; Jim van Eyck; Anneke Kwee; Brent C Opmeer; Maria G van Pampus; Fred K Lotgering; Sicco A Scherjon; Krystyna M Sollie; Marc E A Spaanderman; Christine Willekes; Joris A M van der Post; Ben Willem J Mol
Journal:  BMC Pregnancy Childbirth       Date:  2009-09-01       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.